
Jorge Omar Yanez-Cuna
Skills
Timeline
Professional experience for Jorge Omar Yanez-Cuna
- Current 1 year and 6 months, since Apr 2025
Consultant
Stealth Biotech
- Current 4 years and 11 months, since Nov 2021
Associated Director / Head of R&D
Anjarium Biosciences AG
Led R&D for a rapidly evolving biotech developing non-viral gene delivery and novel DNA technologies. The latter became the core value driver behind its acquisition by National Resilience. I left the company following the relocation of the technology and operations to the USA. - Identified poor translation between in vitro, in vivo models as a critical blocker and designed a multi-omics pipeline to screen 20–40 LNP formulations directly in NHPs. - Built a multidisciplinary team of 10+ scientists.
- 2 years and 10 months, Jan 2019 - Oct 2021
Principal Scientist
Asklepios BioPharmaceutical Inc (AskBio)
Senior scientific role within a pioneering gene therapy (rAAV) company. Directly contributed to two indications now in clinical trials and to AskBio’s acquisition by Bayer for $2Bn. - Led the design and development of AAV regulatory elements using AI/ML, bioinformatics and multi-omics to support multiple programmes. - Owned preclinical design and execution for muscle and cardiac gene therapies, with additional contributions to liver and CNS programmes.
- 1 year and 9 months, Apr 2017 - Dec 2018
Senior Research Scientist
Synpromics LTD
Joined a growing biotech to build the scientific pipeline underpinning its gene therapy partnerships and commercial strategy. The platform formed the scientific foundation for Synpromics’ acquisition by AskBio. - Built the core scientific pipeline integrating AI/ML, multi-omics and preclinical validation to design synthetic promoters for gene therapy. - Delivered nine client programmes across multiple tissues, maintaining alignment with partners such as BioMarin, AGTC, and Solid Biosciences.
- 2 years and 9 months, Jul 2014 - Mar 2017
Postdoctoral Researcher
Netherlands Cancer Institute (NKI)
Working with Bas van Steensel, focusing on gene regulation and multi-omics technology development in a world-class cancer research institute. - Established high-throughput multi-omics screening assays using CRISPR-based and transposon technologies. - Published multiple peer-reviewed papers, including work in Cell, advancing understanding of chromatin organisation.
- 5 years, May 2009 - Apr 2014
PhD Candidate
Research Institute of Molecular Pathology (IMP)
Working with Alexander Stark, pioneered early applications of AI/ML to decode gene regulation using multi-omics data, contributing to the development of STARR-seq and publishing in Nature. - Awarded VBC PhD Award for Outstanding Thesis.
Languages
Spanish
C2 (Expert / native speaker)
English
C1 (Fluent)
French
B1-B2 (Good)
German
B1-B2 (Good)
XING members with similar profiles
XING – The jobs network
Over 1 million jobs
Find just the right job for you on XING.
Job offers just for you
Get found by employers and over 20,000 recruiters.
21 million members
Connect with new people and gather inspiration to boost your working life.
Free membership
Basic membership is free, but the opportunities are priceless.
